Aβ accumulation is significantly reduced in sterile APP mice, but consistently increased in LPS-treated APP mice [32, 137], highlighting the role of LPS, apart from established AD pathogenic factors, and presenting LPS as a potential risk factor, equally strong as AD’s genetic components. This evidence concerns the gene APP and Alzheimer disease.